Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Non-invasive treatments for superficial basal cell carcinoma: PDT vs imiquimod vs 5-fluorouracil
2007-002776-33Phase 3Active
- Sponsor
- Maastricht University Medical Center+
- Start
- Jul 2007
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in basal cell carcinoma (BCC) comparing Metvix photodynamic therapy, Topical imiquimod and Topical fluorouracil (Efudix) (3 arms). Primary endpoint: Treatment failure within 12 months. Started Jul 2007; status: active.
02
Drugs
methyl aminolevulinateimiquimodfluorouracil
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2007-002776-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002776-33.